• Author: Stephen W. Waldo
Clear all

Impact of the MISSION Act on quality and outcomes of major cardiovascular procedures among Veterans

Abstract: Importance: The Department of Veterans Affairs (VA) Maintaining Internal Systems and Strengthening Integrated Outside Networks (MISSION) Act expanded opportunities for …

Management and outcomes of patients undergoing cardiovascular evaluation across health care systems: Comparison of community care and integrated Veterans Affairs health care

Abstract: Background: The Veterans Affairs (VA) Healthcare System maintains the largest integrated health system in the United States but also supports fee‐for‐service …

CYP2C19 polymorphisms and clinical outcomes following percutaneous coronary intervention in the Million Veteran Program

Abstract: CYP2C19 loss-of-function (LOF) alleles decrease the antiplatelet effect of clopidogrel following percutaneous coronary intervention (PCI) in patients presenting with …

Evidence-based SGLT2 inhibitor and GLP-1 receptor agonist use by race in the VA healthcare system

Abstract: Importance: Adoption of novel therapeutics often lags for Black versus non-Hispanic White patients. Seminal clinical trials established the cardiovascular efficacy of …

The quality of Veterans Healthcare Administration cardiovascular care

Abstract: A total of 9 million veterans receive care in a unique healthcare system, the Veterans Healthcare Administration (VHA), with nearly 50% reporting at least one …

Trends and site-level variation of novel cardiovascular medication utilization among patients admitted for heart failure or coronary artery disease in the US Veterans Affairs system: 2017-2021

Abstract: OBJECTIVE: We assessed trends in novel cardiovascular medication utilization in US Veterans Affairs (VA) for angiotensin receptor-neprilysin inhibitors (ARNI), …